Yung-Tai Chen1, Chia-Jen Shih2, Shuo-Ming Ou3, Szu-Chun Hung4, Chi-Hung Lin5, Der-Cherng Tarng6. 1. School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Medicine, Taipei City Hospital Heping Fuyou Branch, Taipei, Taiwan. 2. School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Yuanshan Branch, Yilan, Taiwan. 3. School of Medicine, National Yang-Ming University, Taipei, Taiwan; Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. 4. Division of Nephrology, Taipei Tzu Chi Hospital, Taipei, Taiwan. 5. Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan. 6. School of Medicine, National Yang-Ming University, Taipei, Taiwan; Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department and Institute of Physiology, National Yang-Ming University, Taipei, Taiwan. Electronic address: dctarng@vghtpe.gov.tw.
Abstract
BACKGROUND: The association between periodontal disease and chronic kidney disease in older people is controversial, and evidence for a causal link between kidney function decline and subsequent mortality risk is limited. STUDY DESIGN: Longitudinal, observational, community-based cohort study. SETTING & PARTICIPANTS: Participants were citizens 65 years or older who received the Taipei City Government-sponsored Annual Elderly Health Examination Program during 2005 to 2010, including dental status assessment and biochemical examinations. PREDICTORS: Participants with periodontal disease defined by the World Health Organization Community Periodontal Index of Treatment Need criteria. OUTCOMES: All-cause and cardiovascular mortality and estimated glomerular filtration rate (eGFR) decline ≥ 30% over 2 years. RESULTS: Of 100,263 study participants, 13,749 (13.7%) had periodontal disease. In a mean follow-up of 3.8 years, all-cause and cardiovascular mortality rates in those with periodontal disease (11.5% and 2.6%, respectively) were higher compared with those without periodontal disease (6.7% and 1.6%, respectively). After adjustment for demographic characteristics, comorbid conditions, and biochemistry data, adjusted HRs for all-cause and cardiovascular mortality were 1.34 (95% CI, 1.26-1.42) and 1.25 (95% CI, 1.13-1.41), respectively. The frequency of eGFR decline ≥ 30% over 1-, 2-, and 3-years' follow-up in those with periodontal disease was 1.8%, 3.7%, and 4.0%, respectively. In a logistic regression model, adjusted ORs of the detrimental effect of periodontal disease on 30% eGFR decline in participants over 1-, 2-, or 3-years' follow-up were 1.03 (95% CI, 0.85-1.25), 1.62 (95% CI, 1.41-1.87), and 1.59 (95% CI, 1.37-1.86), respectively. In subgroup analyses according to age, sex, and comorbid conditions, risks for eGFR decline and mortality remained consistent. LIMITATIONS: Results may not be generalizable to other non-Asian ethnic populations. CONCLUSIONS: The results indicate that periodontal disease is a risk factor for all-cause and cardiovascular mortality and eGFR decline ≥ 30% over 2 to 3 years in older people.
BACKGROUND: The association between periodontal disease and chronic kidney disease in older people is controversial, and evidence for a causal link between kidney function decline and subsequent mortality risk is limited. STUDY DESIGN: Longitudinal, observational, community-based cohort study. SETTING & PARTICIPANTS: Participants were citizens 65 years or older who received the Taipei City Government-sponsored Annual Elderly Health Examination Program during 2005 to 2010, including dental status assessment and biochemical examinations. PREDICTORS: Participants with periodontal disease defined by the World Health Organization Community Periodontal Index of Treatment Need criteria. OUTCOMES: All-cause and cardiovascular mortality and estimated glomerular filtration rate (eGFR) decline ≥ 30% over 2 years. RESULTS: Of 100,263 study participants, 13,749 (13.7%) had periodontal disease. In a mean follow-up of 3.8 years, all-cause and cardiovascular mortality rates in those with periodontal disease (11.5% and 2.6%, respectively) were higher compared with those without periodontal disease (6.7% and 1.6%, respectively). After adjustment for demographic characteristics, comorbid conditions, and biochemistry data, adjusted HRs for all-cause and cardiovascular mortality were 1.34 (95% CI, 1.26-1.42) and 1.25 (95% CI, 1.13-1.41), respectively. The frequency of eGFR decline ≥ 30% over 1-, 2-, and 3-years' follow-up in those with periodontal disease was 1.8%, 3.7%, and 4.0%, respectively. In a logistic regression model, adjusted ORs of the detrimental effect of periodontal disease on 30% eGFR decline in participants over 1-, 2-, or 3-years' follow-up were 1.03 (95% CI, 0.85-1.25), 1.62 (95% CI, 1.41-1.87), and 1.59 (95% CI, 1.37-1.86), respectively. In subgroup analyses according to age, sex, and comorbid conditions, risks for eGFR decline and mortality remained consistent. LIMITATIONS: Results may not be generalizable to other non-Asian ethnic populations. CONCLUSIONS: The results indicate that periodontal disease is a risk factor for all-cause and cardiovascular mortality and eGFR decline ≥ 30% over 2 to 3 years in older people.
Authors: Eftychia Kotronia; Heather Brown; A Olia Papacosta; Lucy T Lennon; Robert J Weyant; Peter H Whincup; S Goya Wannamethee; Sheena E Ramsay Journal: Sci Rep Date: 2021-08-12 Impact factor: 4.996
Authors: Marinella Ruospo; Suetonia C Palmer; Germaine Wong; Jonathan C Craig; Massimo Petruzzi; Michele De Benedittis; Pauline Ford; David W Johnson; Marcello Tonelli; Patrizia Natale; Valeria Saglimbene; Fabio Pellegrini; Eduardo Celia; Ruben Gelfman; Miguel R Leal; Marietta Torok; Paul Stroumza; Anna Bednarek-Skublewska; Jan Dulawa; Luc Frantzen; Domingo Del Castillo; Staffan Schon; Amparo G Bernat; Jorgen Hegbrant; Charlotta Wollheim; Letizia Gargano; Casper P Bots; Giovanni Fm Strippoli Journal: BMC Nephrol Date: 2017-05-22 Impact factor: 2.388
Authors: R Ausavarungnirun; S Wisetsin; N Rongkiettechakorn; S Chaichalermsak; U Udompol; M Rattanasompattikul Journal: BMJ Open Date: 2016-07-27 Impact factor: 2.692